The Sevillian biotech seeks to market earlier than 2030 a drugs that may save hundreds of thousands of lives, has no unintended effects and is ingested orally. Read
https://www.elmundo.es/economia/empresas/2026/02/26/699754e021efa015548b459f.html
The Sevillian biotech seeks to market earlier than 2030 a drugs that may save hundreds of thousands of lives, has no unintended effects and is ingested orally. Read
https://www.elmundo.es/economia/empresas/2026/02/26/699754e021efa015548b459f.html